By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Cost of Injection Jumps from $15 to $1,500
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Health Reform > Cost of Injection Jumps from $15 to $1,500
BusinessHealth Reform

Cost of Injection Jumps from $15 to $1,500

JohnCGoodman
JohnCGoodman
Share
2 Min Read
SHARE

The following is from an AP story. See also Merrill Goozner’s comments here.

A drug for high-risk pregnant women has cost about $10 to $20 per injection. Next week, the price shoots up to $1,500 a dose, meaning the total cost during a pregnancy could be as much as $30,000.

That’s because the drug, a form of progesterone given as a weekly shot, has been made cheaply for years, mixed in special pharmacies that custom-compound treatments that are not federally approved ….. But recently, KV Pharmaceutical of suburban St.Louis won government approval to exclusively sell the drug, known as Makena (Mah-KEE’-Nah). ….. The cost is justified to avoid the mental and physical disabilities that can come with very premature births, said KV Pharmaceutical chief executive Gregory J. Divis Jr. The cost of care for a preemie is estimated at $51,000 in the first year alone.To get FDA approval, the company is spending hundreds of millions of dollars in additional research, including an international study involving 1,700 women, Divis said. The FDA last month signed off and gave Makena orphan drug status. That designation ensures Ther-Rx will be the sole source of the drug for seven years.

More Read

Tips to Buy Various Types of Hospital Medication Units
Don’t Worry, ObamaCare Won’t Kill 99 Cent Value Meals
Choosing Wisely and Delivering Value in Obstetrics & Gynecology
Nurses Hold One Day Strike at Kaiser’s Sunset Boulevard Medical Center (Los Angeles) To Bring Attention To Patient Safety
Why did WellPoint buy 1-800-Contacts?

Last month, KV sent cease-and-desist letters to compounding pharmacies, telling them they could face FDA enforcement actions if they kept making the drug.

TAGGED:health care businesshealth care reform
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

weight loss surgeon
How to Choose the Best Surgeon for Weight Loss Surgery
Weight Loss Wellness
February 11, 2026
aging care healthcare system
The Growing Role of Terminal Care Specialists in a Rapidly Aging Healthcare System
Global Healthcare Senior Care
February 11, 2026
Why Trauma and Addiction Are Linked and How Effective Programs Treat Both
Addiction Addiction Recovery
February 10, 2026
car accident injuries
The Hidden Healthcare Impact of Car Accident Injuries
News Policy & Law
February 8, 2026

You Might also Like

Tissue Engineering and Cell Therapy to Grow to Over $30 Billion Global Market

December 6, 2011

Top 10 Unfounded Health Scares of 2011

December 31, 2011
patients in waiting room
Hospital Administration

Patients Are Waiting to Partner: Invite Them to Participate

July 17, 2013

UM Spinoff Takes Rare Adrenal Cancer Drug to Clinical Trials

December 11, 2013
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?